-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.25

Benzinga·02/24/2025 12:52:31
Listen to the news
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4 to $4.25.